$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
先行先试!近日,胆管癌新药英菲格拉替尼在海南开出首张处方
2025-10-19 11:44:20
Check Details
英菲格拉替尼显示出治疗FGFR2改变的晚期胆管癌的潜力
2025-10-19 11:44:20
Check Details
英菲格拉替尼现在在上海能够买到吗?
2025-10-19 11:44:20
Check Details
英菲格拉替尼Truseltiq治疗胆管癌效果显著
2025-10-19 11:44:20
Check Details
佩米替尼片治疗胆管癌疗效如何?治疗时要注意什么
2025-10-19 11:44:20
Check Details
全球首个!美国FDA批准艾伏尼布用于治疗IDH1突变胆管癌
2025-10-19 11:44:20
Check Details
胆管癌靶向药佩米替尼(达伯坦)可显著提高疾病控制率
2025-10-19 11:44:20
Check Details
英菲格拉替尼能与食物同服吗?使用时要注意什么
2025-10-19 11:44:20
Check Details
英菲格拉替尼的用法用量是怎样的?
2025-10-19 11:44:20
Check Details
英菲格拉替尼用药剂量是多少?长期用会耐药吗
2025-10-19 11:44:20
Check Details
英菲格拉替尼哪儿能买,用法用量是怎样的?
2025-10-19 11:44:20
Check Details
英菲格拉替尼进医保了吗,药物不良反应是什么?
2025-10-19 11:44:20
Check Details
1
2
...
27
28
29
30
31
32
33
...
4151
4152
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
A Revolutionary Targeted Therapy for Hematological Malignancies
2
A New Option for Advanced Renal Cell Carcinoma Treatment
3
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
4
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
5
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide
6
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
7
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
8
Comprehensive Analysis of the Third-Generation EGFR-TKI
9
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
10
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison
11
Third-Generation TKI Redefining Treatment for ALK+ & ROS1+ NSCLC
12
Brigatinib Medication Case Study: Three-Year Treatment Record and Experience Sharing of ALK-Positive Lung Cancer Patient